Member Exclusive

Diabetes drug fights memory loss in mice with Alzheimer’s

Originally developed to treat type 2 diabetes, the triple GLP-1/GIP/glucagon receptor agonist was found to 'significantly reverse memory loss'.

Go to the profile of Freya Leask
Jan 03, 2018

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.


No comments yet.